FDA Inspection 1245821 — Komal L. Jhaveri, M.D.
The FDA completed an inspection of Komal L. Jhaveri, M.D. on July 26, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
Clinical Investigator (CI)